Clinical Trial Update: Dupilumab Therapy for EGIDs

View source ↗

Summary

Dupilumab is being studied for eosinophilic gastrointestinal disorders and the trial is currently recruiting. Recruitment is taking place at the Children's Hosp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Gastrointestinal Disorders

Drugs mentioned

• Dupixent (dupilumab) (dupilumab)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs) | Status: RECRUITING